Selective serotonin reuptake inhibitors (SSRIs) for treatment of COPD

This technology is a mesh scaffold capable of growing probiotic strains against respiratory pathogens that can be used for the prevention and treatment of Chronic Obstructive Pulmonary Disease (COPD).

Probiotic prevention of COPD and other respiratory diseases.

Addresses disease progression of COPD.

This technology is a method for selective de-epithelialization of lung tissue to treat lung diseases or improve donor lung tissue health for transplant applications.

Research tool for studying mechanisms of lung repair.

Unmet Need: Model for studying cellular regeneration in lungs.

Treatment of childhood interstitial lung disease (chILD), idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), familial idiopathic pulmonary fibrosis, neonatal respiratory distress, an epithelial lung disease, a disease initiated by chronic epithelial injury, or an interstitial lung disease.

“A distal lung organoid model to study interstitial lung disease, viral infection and human lung development.